drugset

drugset / Trial / NCT00631748

Quetiapine for the Reduction of Cocaine Use

NCT00631748 ↗

Completed 60 enrolled Seattle Institute for Biomedical and Clinical Research AstraZeneca · collab VA Puget Sound Health Care System · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This placebo-controlled trial will test the effectiveness of Seroquel XR™ for the treatment of cocaine dependence in non-psychotic individuals who are cocaine dependent.

Timeline

Start: 2008-02
Primary completion: 2010-07
Completion: 2010-07

Publications

Background Kennedy A, Wood AE, Saxon AJ, Malte C, Harvey M, Jurik J, Kilzieh N, Lofgreen C, Tapp A. Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol. 2008 Apr;28(2):221-4. doi: 10.1097/JCP.0b013e318166f50d.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Quetiapine	Small molecule	50 mg	—
Subject	Quetiapine	Small molecule	100 mg	—
Subject	Quetiapine	Small molecule	200 mg	—
Subject	Quetiapine	Small molecule	300 mg	—
Subject	Quetiapine	Small molecule	400 mg	—

Indications